Evidence map›Paper›PMID 39852834›Full record

ArticleVaccines2025

Barriers and Predictors of Lyme Disease Vaccine Acceptance: A Cross-Sectional Study in Poland.

Dawid Lewandowski, Artur Sulik, Filip Raciborski, Milena Krasnodebska, Joanna Gebarowska, Aleksandra Stalewska, Kacper Toczylowski

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dawid LewandowskiDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, 15-274 Bialystok, Poland.
Artur SulikDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, 15-274 Bialystok, Poland.ORCID 0000-0002-8391-4793
Filip RaciborskiDepartment of Environmental Hazard Prevention, Allergology and Immunology, Warsaw Medical University, 02-007 Warsaw, Poland.ORCID 0000-0003-0562-0260
Milena KrasnodebskaDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, 15-274 Bialystok, Poland.
Joanna GebarowskaDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, 15-274 Bialystok, Poland.
Aleksandra StalewskaDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, 15-274 Bialystok, Poland.
Kacper ToczylowskiDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, 15-274 Bialystok, Poland.ORCID 0000-0003-0309-6987

Funding

Medical University of Bialystok B.SUB.24.448
6 · The paper itself

Abstract

BACKGROUND/

objectivesLyme disease (LD) is a major public health problem in Europe and the United States, with increasing incidence and not many prevention options. Vaccine hesitancy might be a significant barrier to successful vaccination campaigns having in mind previous vaccine development failures. This study aimed to evaluate the public's perception of LD vaccination in Poland, assess willingness to vaccinate, and identify factors influencing vaccination attitudes.

methodsA cross-sectional survey was conducted among parents of children hospitalized at the University Children's Hospital in Bialystok, Poland. The survey consisted of 29 questions regarding demographics, LD knowledge, vaccine attitudes, and perceived risks. Data were collected between January and December 2023 and analyzed using descriptive and inferential statistics to identify predictors of respondents' positive vaccination attitudes.

resultsA total of 503 valid responses were analyzed. Most respondents (72.4%) showed positive attitudes towards vaccination, while 18.5% were neutral and 9.1% were negative. Trust in health experts emerged as an important predictor of vaccination acceptance (OR 22.84;

conclusionsPublic perception of LD in Poland indicates a high acceptance of a potential LD vaccine. Still, addressing vaccine hesitancy remains critical, particularly among undecided or neutral respondents. Building trust in healthcare professionals and addressing safety worries are important to increasing future LD vaccine use.

Indexed as

healthcare trustLyme diseasePolandpreventive medicinepublic healthtick-borne diseasesvaccination attitudesvaccine acceptancevaccine hesitancy

Identifiers

PMID39852834
PMCPMC11769240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.